UBS AM’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2M Buy
229,672
+50,917
+28% +$2.49M ﹤0.01% 1303
2025
Q1
$9.11M Buy
178,755
+18,504
+12% +$943K ﹤0.01% 1270
2024
Q4
$7.23M Buy
160,251
+26,274
+20% +$1.19M ﹤0.01% 1413
2024
Q3
$4.97M Sell
133,977
-18,425
-12% -$684K ﹤0.01% 1574
2024
Q2
$4.66M Buy
152,402
+73,305
+93% +$2.24M ﹤0.01% 1531
2024
Q1
$2.3M Hold
79,097
﹤0.01% 1626
2023
Q4
$2.18M Buy
79,097
+3,371
+4% +$92.9K ﹤0.01% 1652
2023
Q3
$1.7M Buy
75,726
+2,236
+3% +$50.1K ﹤0.01% 1709
2023
Q2
$3.56M Hold
73,490
﹤0.01% 1382
2023
Q1
$3.56M Buy
73,490
+5,621
+8% +$272K ﹤0.01% 1382
2022
Q4
$2.59M Sell
67,869
-194,100
-74% -$7.41M ﹤0.01% 1417
2022
Q3
$13.2M Sell
261,969
-14,286
-5% -$717K 0.01% 872
2022
Q2
$11.1M Sell
276,255
-190,951
-41% -$7.65M 0.01% 924
2022
Q1
$17.4M Sell
467,206
-13,008
-3% -$485K 0.01% 877
2021
Q4
$19.1M Buy
480,214
+2,904
+0.6% +$116K 0.01% 908
2021
Q3
$17.8M Buy
477,310
+16,910
+4% +$629K 0.01% 901
2021
Q2
$19.5M Buy
460,400
+144,198
+46% +$6.1M 0.01% 890
2021
Q1
$15M Sell
316,202
-127,940
-29% -$6.06M 0.01% 951
2020
Q4
$27.1M Buy
444,142
+16,702
+4% +$1.02M 0.01% 766
2020
Q3
$20M Sell
427,440
-64,342
-13% -$3.01M 0.01% 763
2020
Q2
$25M Buy
491,782
+123,696
+34% +$6.28M 0.02% 679
2020
Q1
$16.4M Sell
368,086
-30,520
-8% -$1.36M 0.01% 724
2019
Q4
$19.1M Buy
398,606
+27,378
+7% +$1.31M 0.01% 787
2019
Q3
$12.6M Buy
371,228
+5,881
+2% +$199K 0.01% 883
2019
Q2
$16.4M Buy
365,347
+58,247
+19% +$2.62M 0.01% 812
2019
Q1
$11.6M Buy
307,100
+31,489
+11% +$1.19M 0.01% 891
2018
Q4
$9.46M Buy
275,611
+17,367
+7% +$596K 0.01% 892
2018
Q3
$12.1M Sell
258,244
-16,064
-6% -$755K 0.01% 886
2018
Q2
$9.25M Sell
274,308
-28,800
-10% -$971K 0.01% 965
2018
Q1
$8.2M Sell
303,108
-58,385
-16% -$1.58M 0.01% 986
2017
Q4
$6.03M Buy
361,493
+32,396
+10% +$540K 0.01% 1049
2017
Q3
$6.59M Sell
329,097
-58,800
-15% -$1.18M 0.01% 1003
2017
Q2
$7.11M Sell
387,897
-228,060
-37% -$4.18M 0.01% 959
2017
Q1
$6.06M Buy
615,957
+15,345
+3% +$151K 0.01% 987
2016
Q4
$6.55M Sell
600,612
-7,465
-1% -$81.4K 0.01% 942
2016
Q3
$8.52M Sell
608,077
-7,454
-1% -$104K 0.01% 912
2016
Q2
$4.32M Sell
615,531
-20,769
-3% -$146K ﹤0.01% 1055
2016
Q1
$4.1M Buy
636,300
+161,590
+34% +$1.04M ﹤0.01% 1077
2015
Q4
$15.4M Sell
474,710
-19,218
-4% -$623K 0.02% 757
2015
Q3
$13.2M Buy
493,928
+131,153
+36% +$3.5M 0.01% 804
2015
Q2
$17.5M Buy
362,775
+54,175
+18% +$2.61M 0.02% 757
2015
Q1
$18.8M Buy
308,600
+4,000
+1% +$243K 0.02% 727
2014
Q4
$15.8M Buy
304,600
+31,000
+11% +$1.6M 0.02% 755
2014
Q3
$12M Buy
+273,600
New +$12M 0.01% 791